Business Wire

Philips Introduces New SpeechExec Enterprise Dictation and Transcription Software

Jaa

Speech Processing Solutions, the world number one in professional dictation, announced their latest speech-to-text software Philips SpeechExec Enterprise. The new sophisticated workflow management software allows busy healthcare, legal and business professionals to streamline their document creation process and significantly reduce their workload.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180417005035/en/

Philips SpeechExec Enterprise

Philips SpeechExec Enterprise

Smarter communication and convenient central administration

The dictation and transcription software facilitates communication by linking authors and transcriptionists. Whether the user works in a hospital, or a legal practice, the software is ideal for turning their voice into text quicker, and more efficiently than ever before. Dr. Thomas Brauner, CEO of Speech Processing Solutions explains: “Philips SpeechExec Enterprise is perfect for larger organizations with multiple authors and transcriptionists, as it can easily be centrally administrated and maintained.” All workflow settings, as well as the hardware input devices, can be centrally administrated and configured. The solution is also Microsoft Remote Desktop Services (RDS), Citrix and VMware ready, making the installation process easier and more convenient for both users and IT administrators.

Full mobility for increased productivity

The new version of Philips’ SpeechExec Enterprise offers full mobility, meaning recordings can created anywhere and sent for transcription immediately. Even if the user is out of the office, they can download the brand-new Philips Voice Recorder App to their smartphone and send their recordings directly to their assigned transcriptionists.

Geared for on the go speech recognition

The software now even works seamlessly with Philips SpeechLive transcription and speech recognition service, allowing users to receive their transcribed files directly to their smartphone or Philips SpeechAir Voice Recorder. Another new mobility enhancing feature is that dictations can now even be accessed through a web browser. This can be particularly useful when an individual wants to use their solution on a business trip, without access to their standard computer.

Secure file transfer

Real-time file encryption (256 bit), password protection and secure file transfer grant only authorized individuals to access documents. The optional automatic backup function protects data against accidental loss. Dr. Brauner explains: “We know exactly how important security is to our customers working with sensitive data, such as patient records or legal cases. This is why our software adheres to the highest of security standards and we now even offer support for your private cloud environment“.

To find out more about the new software, visit: www.philips.com/dictation

Download the Philips Voice Recorder App now: https://www.dictation.philips.com/products/mobile-dictation/voice-recorder-app-lfh7400/

About Speech Processing Solutions

Speech Processing Solutions is the global number one in professional dictation solutions. Founded in Austria in 1954 as part of Philips, the company has been the driving force behind innovative speech-to-text solutions for over 60 years. The company has developed ground-breaking products, such as the mobile Philips SpeechAir device, the Philips PocketMemo voice recorder, the Philips SpeechMike Premium USB dictation microphone and the Philips voice recorder app for smartphones, thus delivering its promise of excellence and outstanding quality. Thanks to the latest innovation, Philips SpeechLive, designed as a cloud-based workflow solution, recording dictations is quicker and easier than ever. The tailored range of products and services offered by Speech Processing Solutions helps professional users to save time and resources and to work at maximum efficiency.

Follow Speech Processing Solutions:

Facebook: http://www.facebook.com/philipsvoicetracer

Instagram: https://www.instagram.com/philips_dictation/

Twitter @speech_com: http://www.twitter.com/speech_com

YouTube: http://www.youtube.com/philipsdictation

LinkedIn: http://www.linkedin.com/company/speech-processing-solutions

Contact information

Speech Processing Solutions
Lea Pachta
lea.pachta@speech.com
Tel: +43 160529-1744
www.philips.com/dictation

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Manchester United and True Religion Launch Denim Range19.10.2018 20:37Tiedote

Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion

Arch Insurance Announces Strategic Leadership Changes19.10.2018 16:10Tiedote

Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 15:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an

Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 14:54Tiedote

Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr

Tradeshift Announces Q3 2018 Results19.10.2018 14:00Tiedote

Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between

Schlumberger Announces Third-Quarter 2018 Results19.10.2018 14:00Tiedote

Schlumberger Limited (NYSE: SLB) today reported results for the third quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Sept. 30, 2018 Jun. 30, 2018 Sept. 30, 2017 Sequential Year-on-year Revenue $8,504 $8,303 $7,905 2% 8% Pretax operating income $1,152 $1,094 $1,059 5% 9% Pretax operating margin 13.5% 13.2% 13.4% 36 bps 15 bps Net income - GAAP basis $644 $430 $545 50% 18% Net income, excluding charges & credits* $644 $594 $581 8% 11% Diluted EPS - GAAP basis $0.46 $0.31 $0.39 48% 18% Diluted EPS, excluding charges & credits* $0.46 $0.43 $0.42 7% 10% North America revenue $3,189 $3,139 $2,602 2% 23% International revenue $5,215 $5,065 $5,147 3% 1% North America revenue, excluding Cameron $2,572 $2,546 $2,086 1% 23% International revenue, excluding Cameron $4,559 $4,387 $4,430 4% 3% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commented, “Our third

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme